...
首页> 外文期刊>World Journal of Gastroenterology >Influence of perfusate on liver viability during hypothermic machine perfusion
【24h】

Influence of perfusate on liver viability during hypothermic machine perfusion

机译:灌注液对低温体温灌注过程中肝脏生存能力的影响

获取原文
           

摘要

AIM: To optimize the perfusates used for hypothermic machine perfusion (HMP). METHODS: Sprague-Dawley rats were assigned randomly to three groups (n = 12 per group) that received either saline, University of Wisconsin cold-storage solution (UW) or histidine-tryptophan-ketoglutarate solution (HTK) as the perfusate. Each group was divided into two subgroups: static cold storage (SCS) and HMP (n = 6 per subgroup). The liver graft was retrieved according to the method described by Kamada. For the SCS group, the graft was directly placed into cold perfusate (0-4?°C) for 6 h after liver isolation while the portal vein of the graft was connected to the perfusion machine for the HMP group. Then the perfusates were collected at different time points for analysis of aspartate aminotransferase (AST), alanine transaminase (ALT) and lactate dehydrogenase (LDH) levels. Liver tissues were obtained for evaluation of histology, dry/wet weight (D/W) ratio, and malondialdehyde (MDA) and adenosine-triphosphate (ATP) levels. The portal vein pressure and velocity were monitored in real time in all HMP subgroups. RESULTS: Comparison of HMP and SCS: Regardless of the perfusate, HMP improved the architecture of donor graft in reducing the congestion around sinusoids and central vein and maintaining sinusoid lining in morphology; HMP improved liver function in terms of ALT, AST and LDH, especially during the 3-6 h period (SCS vs HMP using saline: ALT3, 225.00 ± 105.62 vs 49.50 ± 18.50, P = 0.047; LDH3, 1362.17 ± 563.30 vs 325.75 ± 147.43, P = 0.041; UW: LDH6, 2880.14 ± 948.46 vs 2135.00 ± 174.27, P = 0.049; HTK, AST6, 307.50 ± 52.95 vs 185.20 ± 20.46, P = 0.041); HMP decreased MDA level (saline, 2.79 ± 0.30 vs 1.09 ± 0.09, P = 0.008; UW, 3.01 ± 0.77 vs 1.23 ± 0.68, P = 0.005; HTK, 3.30 ± 0.52 vs 1.56 ± 0.22, P = 0.006). Comparison among HMP subgroups: HTK showed less portal vein resistance than UW and saline (vs saline, 3.41 ± 0.49 vs 5.00 ± 0.38, P vs UW, 3.41 ± 0.49 vs 4.52 ± 0.63, P = 0.007); UW reduced edema most efficiently (vs saline, 0.68 ± 0.02 vs 0.79 ± 0.05, P = 0.013), while HTK maintained ATP levels best (vs saline, 622.60 ± 29.11 vs 327.43 ± 44.66, P vs UW, 622.60 ± 29.11 vs 301.80 ± 37.68, P CONCLUSION: HMP is superior to SCS in maintaining both architecture and function of liver grafts. Further, HTK was found to be the optimal perfusate for HMP.
机译:目的:优化用于低温机器灌注(HMP)的灌注液。方法:将Sprague-Dawley大鼠随机分为三组(每组n = 12),分别接受盐水,威斯康星大学冷藏溶液(UW)或组氨酸-色氨酸-酮戊二酸溶液(HTK)作为灌流液。每个组分为两个子组:静态冷藏(SCS)和HMP(每个子组n = 6)。根据Kamada描述的方法取回肝移植物。对于SCS组,将肝脏隔离后的移植物直接置于冷灌注液(0-4°C)中6 h,同时将移植物的门静脉连接至HMP组的灌注机。然后在不同时间点收集灌流液,以分析天冬氨酸转氨酶(AST),丙氨酸转氨酶(ALT)和乳酸脱氢酶(LDH)的水平。获得肝组织用于组织学,干/湿重(D / W)比以及丙二醛(MDA)和三磷酸腺苷(ATP)水平的评估。在所有HMP亚组中实时监测门静脉压力和速度。结果:HMP和SCS的比较:无论灌注液如何,HMP都改善了供体移植物的结构,从而减少了正弦波和中央静脉周围的充血并维持了正弦波衬里的形态。 HMP改善了ALT,AST和LDH的肝功能,尤其是在3-6小时期间(SCS vs HMP生理盐水:ALT3,225.00±105.62 vs 49.50±18.50,P = 0.047; LDH3,1362.17±563.30 vs 325.75± 147.43,P = 0.041; UW:LDH6,2880.14±948.46 vs 2135.00±174.27,P = 0.049; HTK,AST6,307.50±52.95 vs 185.20±20.46,P = 0.041); HMP降低了MDA水平(盐水,2.79±0.30 vs.1.09±0.09,P = 0.008; UW,3.01±0.77 vs 1.23±0.68,P = 0.005; HTK,3.30±0.52 vs 1.56±0.22,P = 0.006)。 HMP亚组之间的比较:HTK显示的门静脉阻力低于UW和生理盐水(与生理盐水相比,分别为3.41±0.49 vs 5.00±0.38,P vs UW,3.41±0.49 vs 4.52±0.63,P = 0.007); UW最有效地减轻水肿(vs生理盐水,0.68±0.02 vs. 0.79±0.05,P = 0.013),而HTK保持最佳的ATP水平(vs生理盐水,622.60±29.11 vs 327.43±44.66,P vs UW,622.60±29.11 vs 301.80± 37.68,P结论:HMP在维持肝移植物的结构和功能方面优于SCS,而且,HTK被认为是HMP的最佳灌注液。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号